ZEB1 and metastatic malignant neoplasm in the lymph nodes: Between ZEB1 expression in patients with lymph node metastasis (5.31 ± 3.15) and without lymph node metastasis (3.37 ± 3.02), a significant difference has been found (P < 0.001).